Nureca (NURECA.NS) Stock Price

Nureca Price

CLOSED
313.25
​
Market closed

Revenue has compounded at 169.2% per year over the past 9 years to 1.47 B INR. Earnings per share have grown at 173.3% per year over the last 9 years. Nureca's net margin stands at 1.4%, down from 17.6% several years earlier. Nureca currently offers a dividend yield of about 0.96%. The payout ratio is around 7% of earnings.

Nureca stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nureca business model & stock analysis

Nureca Ltd is a health care company headquartered in Mumbai, India, with 102 employees. The company went public via an IPO on February 25, 2021. Nureca designs and manufactures health monitoring devices, offering a range of products across several categories. Its chronic disease products include nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers. Orthopedic products consist of wheelchairs, walkers, lumbar and tailbone supports, and physiotherapy electric massagers. Mother and child products feature baby feeding items, carry cots, baby skincare, nebulizers, bottle warmers, and steamers. Nutrition supplements include weight management products. Lifestyle products encompass humidifiers, steamers, personal scales, massagers, fitness tracking devices, and dental and personal care items. The company markets its products under brands such as Dr Trust, Dr Physio, and Trumom. Nureca's website is https://www.nureca.com/ and it operates within the health care sector in India. The company does not disclose additional details about its founding year, specific acquisitions, or financial figures beyond the IPO date and employee count.

Frequently asked questions about Nureca

Converted at the current exchange rate, the Nureca share trades at 2.94 EUR (313.25 INR).

The revenue of Nureca is 1.47 B INR. This figure is based on current financial data and reflects the company's business performance.

The profit of Nureca is 20.82 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Nureca is currently 143.56. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Nureca stock.

The price-to-sales ratio (P/S) of Nureca is currently 2.03. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Nureca stock.

The Eulerpool Quality Score for Nureca is 3/10.

The ISIN of Nureca is INE0DSF01015. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Nureca is NURECA.NS. The ticker symbol is used to trade Nureca shares on the stock exchange.

Fair ValueTerminal
285.06 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Equipment & Supplies
Number of shares
Employees
Revenue per Employee
14.41 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website nureca.com
Country
Currency
INR
Initial public offering
Feb 25, 2021
ISIN
INE0DSF01015
Cusip
Y6S8G2101
Market capitalization
2.99 B INRMid Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
39.94
P/B Ratio
1.65
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
1.14 %
Dividend
Dividend yield
0.00 %
Payout Ratio
5.64 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Oct 19, 2026, 11:12 PM

Nureca Peer Group

Nureca FIGI

NURECA:IN · BBG00Z6G7D31NURECA:IB · BBG00Z6G7D40NURECA:IS · BBG00Z6G7D68

All fundamentals and in-depth analysis of Nureca

Our stock analysis for Nureca stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Nureca. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.